Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).

The World Health Organisation (WHO) has raised concern over the stagnation of global HIV prevention efforts, announcing ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

For some people, HIV feels like something that happens to “other people.” It’s a distant issue — something for a different ...

Black women make up just 13% of the U.S. female population, yet they account for over 50% of new HIV diagnoses among women, according to the Kaiser Family Foundation (KFF). That means more than half ...

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...

"Uganda is also close to the elimination of mother-to-child to child transmission of HIV. We see that we are performing at six percent. The target is less than five percent. So we are close, and we ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...